Transcept Pharmaceuticals Inc 4
4 · Transcept Pharmaceuticals Inc · Filed Jul 18, 2013
Insider Transaction Report
Form 4
Kollins John A
SVP, Chief Business Officer
Transactions
- Award
Common Stock Option (right to buy)
2013-07-15+115,000→ 115,000 totalExercise: $2.93Exp: 2023-07-15→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]The option vests in forty-eight equal monthly installments beginning on August 15, 2013.